AstraZeneca reportedly made $10 billion bid for Rhythm Pharmaceuticals
AZN•AstraZeneca reportedly made an about $10 billion offer to acquire rare-disease drugmaker Rhythm Pharmaceuticals, the Wall Street Journal reported, citing people familiar with the matter.
1. Acquisition offer
AstraZeneca made an offer of about $10 billion to acquire Rhythm Pharmaceuticals, the Wall Street Journal reported, citing people familiar with the matter.
